COSRX vs Medik8:Which is searched more?
In September 2026, COSRX and Medik8 were level on Share of Search among face cleanser brands worldwide, with an estimated 402K versus 429K branded searches, at 3% and 3.2% estimated Share of Search. These are worldwide searches for English-language branded terms.
Follow COSRX vs Medik8 and get free monthly updates on what changed
By continuing you'll get index updates and occasional product news from Brandwave. Unsubscribe any time. Privacy
Which is more popular in search, COSRX or Medik8?
Compare the face cleanser brands people buy. Branded searches tell you how often people look for a brand by name or related terms. Comparing these searches across competitors helps you see how popular each brand is over time.
Share of Search by month for Medik8, COSRX. The figures are in the table below the chart.
View monthly share of search table
| Month | Cetaphil | CeraVe | La Roche-Posay | The Ordinary | Beauty of Joseon | Garnier | Neutrogena | Eucerin | Bioderma | Kiehl's | Medik8 | COSRX | Aveeno | SKIN1004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2025 | 15.4% | 17% | 13.6% | 9.1% | 5.9% | 7.4% | 7.7% | 5% | 4.1% | 5% | 2.7% | 3.1% | 2.5% | 1.6% |
| Nov 2025 | 14.4% | 14.3% | 13.5% | 12.7% | 6.8% | 5.4% | 6.1% | 5% | 4.1% | 7.4% | 3.2% | 3% | 2.2% | 2% |
| Dec 2025 | 14.8% | 16.2% | 15.2% | 10% | 6.3% | 6% | 7.4% | 4.6% | 3.7% | 5.6% | 2.5% | 3.5% | 2.6% | 1.8% |
| Jan 2026 | 15.8% | 15.7% | 14.8% | 9.7% | 7.5% | 5.6% | 7.1% | 4.4% | 4.4% | 4.4% | 2.9% | 3.3% | 2.5% | 1.8% |
| Feb 2026 | 15.1% | 16.6% | 16.3% | 8.9% | 7.1% | 6.2% | 7.5% | 4.9% | 4% | 4% | 2.6% | 3% | 2.3% | 1.6% |
| Mar 2026 | 13.8% | 14.7% | 17.2% | 9.4% | 7.5% | 6.4% | 7.4% | 5.2% | 4.2% | 4.2% | 2.8% | 3.1% | 2.3% | 1.7% |
| Apr 2026 | 13.6% | 14.6% | 17% | 11% | 7.9% | 6.2% | 7.2% | 5.1% | 4.2% | 3.4% | 2.7% | 3.1% | 2.2% | 1.6% |
| May 2026 | 12.8% | 15% | 17.8% | 9.4% | 8.3% | 6.5% | 7.5% | 5.3% | 4.4% | 3.6% | 2.3% | 3.3% | 2.1% | 1.7% |
| Jun 2026 | 13.7% | 15.7% | 15.7% | 10% | 8.9% | 7.3% | 6.9% | 4.7% | 3.8% | 3.8% | 2.4% | 2.9% | 2.3% | 1.8% |
| Jul 2026 | 14.8% | 15.9% | 15.9% | 10.1% | 7.4% | 7.5% | 6.8% | 4.8% | 3.9% | 3.2% | 3% | 2.9% | 2.4% | 1.5% |
| Aug 2026 | 14.3% | 15.7% | 15.4% | 9.7% | 7.2% | 7.5% | 8.1% | 4.6% | 3.8% | 3.8% | 2.9% | 2.8% | 2.3% | 1.8% |
| Sep 2026 | 15.4% | 14.4% | 13.8% | 10.6% | 7.8% | 7.3% | 7% | 5.1% | 4.1% | 4.1% | 3.2% | 3% | 2.5% | 1.6% |
How has the COSRX and Medik8 comparison changed over the last 12 months?
3 findings
- The lead changed hands 3 times in the 12 months ending September 2026: Medik8 took it in November 2025, COSRX took it in December 2025, Medik8 took it in July 2026.
- Across the 12 months ending September 2026, COSRX’s estimated Share of Search among face cleanser brands worldwide moved from 3.1% to 3%, and its estimated monthly branded searches moved from 413K to 402K.
- Across the 12 months ending September 2026, Medik8’s estimated Share of Search among face cleanser brands worldwide moved from 2.7% to 3.2%, and its estimated monthly branded searches moved from 362K to 429K.
How did search popularity change for face cleanser brands worldwide in September 2026?
1 change
Estimated monthly branded searches for Medik8 worldwide rose 18.5% over 12 measured months, from 362K to 429K in September 2026.
Other head-to-heads among face cleanser brands
Cetaphil vs CeraVe: compare search popularityCetaphil vs La Roche-Posay: compare search popularity
Cetaphil vs The Ordinary: compare search popularity
Cetaphil vs Beauty of Joseon: compare search popularity- CeraVe vs The Ordinary: compare search popularity
How each brand is measured
Brandwave collects information about searches that people make online using COSRX’s and Medik8’s names. When viewed over time, estimated search volumes for these branded terms can be used to understand whether interest in the brands is growing, holding steady, or fading.
Put your own brand in this comparison
Brandwave tracks your branded demand next to the rival you actually watch, with your campaigns, spend and outcomes on the same timeline.